Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorocarbon-based oxygen carriers: new orientations.

J G Riess1

  • 1Laboratoire de Chimie Moléculaire, Université de Nice-Sophia Antipolis, France.

Artificial Organs
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Therapeutic oxygen delivery by perfluorocarbon-based colloids'" [Advances in Colloid and Interface Science 294 (2021) 102407].

Advances in colloid and interface science·2021
Same author

Use of Lymphoblastoid Namalva Cell Cultures in a Toxicity Test. Application to the Monitoring of Detoxification Procedures for Fluorocarbons to be used as Intravascular Oxygen-Carriers.

Pharmaceutical research·2013
Same author

Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology.

Chemical reviews·2001
Same author

Carbohydrate- and related polyol-derived fluorosurfactants: an update.

Carbohydrate research·2000
Same author

Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions.

Surgery·2000
Same author

Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery.

Biomaterials·1998
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

Second-generation fluorocarbon emulsions offer improved oxygen carriers for medical applications. Research focuses on optimizing these injectable oxygen carriers and developing new surfactants for enhanced emulsion properties.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Pharmacology

Background:

  • Fluosol, a first-generation fluorocarbon emulsion, is approved for myocardial oxygenation during angioplasty.
  • Advancements in fluorocarbon and emulsion technology have yielded improved injectable oxygen carriers.
  • Fluorocarbons show promise for new diagnostic and therapeutic medical applications.

Purpose of the Study:

  • To highlight advancements in second-generation injectable oxygen carriers.
  • To discuss the potential of fluorocarbons in diagnostics and therapeutics.
  • To emphasize the role of emulsifiers in optimizing fluorocarbon emulsion properties.

Main Methods:

  • Review of improvements in fluorocarbon and emulsion technology.
  • Discussion of potential applications in diagnostics and therapeutics.

Related Experiment Videos

  • Focus on the development and evaluation of novel surfactants for fluorocarbon emulsification.

    • Main Results:

    • Development of more stable and efficient second-generation injectable oxygen carriers.
    • Expanded potential for fluorocarbons in medical diagnostics and therapeutics.
    • Identification of emulsifiers as critical for controlling emulsion characteristics.

    Conclusions:

    • Second-generation fluorocarbon emulsions represent a significant advancement in oxygen carrier technology.
    • Optimizing emulsion characteristics through surfactant development is key for specific medical applications.
    • Fluorocarbons hold considerable future potential in both diagnostic and therapeutic medicine.